Phathom Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-…

Biotechnology
US, Florham Park [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of PHAT's Analysis
CIK: 1783183 CUSIP: 71722W107 ISIN: US71722W1071 LEI: - UEI: -
Secondary Listings
PHAT has no secondary listings inside our databases.